Inovio Pharmaceuticals, Inc. (INO) Presents at H.C. Wainwright 24th Annual Global Investment Conference (Transcript)

Sep. 12, 2022 1:10 PM ETInovio Pharmaceuticals, Inc. (INO)
SA Transcripts profile picture
SA Transcripts
133.8K Followers

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) H.C. Wainwright 24th Annual Global Investment Conference September 12, 2022 7:00 AM ET

Company Participants

Jacqueline Shea - President and CEO

Conference Call Participants

Brooke Katsof - H.C. Wainwright

Brooke Katsof

Good morning, everyone and thank you for joining the H.C. Wainwright 24th Annual Global Investment Hybrid Conference from September 12 to the 14, 2022. My name is Brooke Katsof and I'm an H.C. Wainwright analyst. While we are hybrid this year, we're confident we are going to be able to provide value to you with over 550 companies presenting at this conference and multiple sector tracks devoted to Life Sciences cryptocurrency, blockchain and fintech technology, media and telecommunications, clean tech metals and mining and growth.

H.C. Wainwright is a full service investment bank dedicated to providing corporate finance strategic advisory and related services to public and private companies across multiple sectors and regions. We have a total of 26 publishing senior analysts and over 643 companies covered across all sectors. Please visit each hcw.co.com for more information. Please join us for one-on-one meetings, corporate presentations and panels that will be available live and streaming on September 12 to the 14.

With that said, have a productive and enjoyable day and I'd like to introduce our first presenter. I'd like to welcome Jacquie Shea, who's the President and CEO of the Inovio Pharmaceuticals.

Jacqueline Shea

Thank you, Brooke. Good morning and thank you for joining in Inovio's corporate presentation at the H.C. Wainwright Global Investment Conference. Today's presentation is being recorded on [September 7], 2022. I will be making forward-looking statements regarding future events and the Company's future performance. These statements are based on beliefs and expectations of today and actual events or results could differ materially.

Inovio is a DNA medicines company. All of our product

Recommended For You

Comments

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.